160 related articles for article (PubMed ID: 24133592)
21. NOB1 in non-small-cell lung cancer: expression profile and clinical significance.
Liu K; Gu MM; Chen HL; You QS
Pathol Oncol Res; 2014 Apr; 20(2):461-6. PubMed ID: 24272676
[TBL] [Abstract][Full Text] [Related]
22. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B
Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma.
Li W; Liu M; Feng Y; Xu YF; Che JP; Wang GC; Zheng JH; Gao HJ
Int J Clin Exp Pathol; 2013; 6(6):1086-94. PubMed ID: 23696926
[TBL] [Abstract][Full Text] [Related]
24. Expression of NM23 and tenascin in invasive ductal carcinomas of the breast.
Kaya H; Hücümenoğlu S; Bozkurt SU; Ekicioğlu G; Kotiloğlu E
Eur J Gynaecol Oncol; 2002; 23(3):261-3. PubMed ID: 12094967
[TBL] [Abstract][Full Text] [Related]
25. Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.
Makdissi FB; Machado LV; Oliveira AG; Benvenuti TT; Katayama ML; Brentani MM; Osório CA; Mourão Netto M; Lyra EC; Carvalho F; Góes JC; Folgueira MA
Braz J Med Biol Res; 2009 Dec; 42(12):1128-37. PubMed ID: 19893985
[TBL] [Abstract][Full Text] [Related]
26. [The clinical significance of P-glycoprotein, lung resistance protein and multidrug resistance related protein expressions in infiltrating breast carcinoma tissues].
Zuo WS; Wei L; Song XR; Wang XW; Wang MY; Wang YS; Yu ZY; Bi Y
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3142-5. PubMed ID: 17313768
[TBL] [Abstract][Full Text] [Related]
27. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
[TBL] [Abstract][Full Text] [Related]
28. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
29. [Expression of the genes FHIT, Bcl-2 and Bax in breast infiltrating ductal carcinoma and clinicopathological significance thereof].
Wang ZB; Zhao P; Liu M; Li XH
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(31):2171-6. PubMed ID: 17064501
[TBL] [Abstract][Full Text] [Related]
30. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis.
Han Z; Chen Z; Zheng R; Cheng Z; Gong X; Wang D
World J Surg Oncol; 2015 Feb; 13():56. PubMed ID: 25889325
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast.
Zhao H; Chen D; Wang J; Yin Y; Gao Q; Zhang Y
Int J Clin Exp Pathol; 2014; 7(2):670-6. PubMed ID: 24551288
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
[TBL] [Abstract][Full Text] [Related]
34. Correlated expression of Fas, NF-kappaB, and VEGF-C in infiltrating ductal carcinoma of the breast.
Dai XL; Zhou SL; Qiu J; Liu YF; Hua H
Eur J Gynaecol Oncol; 2012; 33(6):633-9. PubMed ID: 23327061
[TBL] [Abstract][Full Text] [Related]
35. Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an immunohistochemical and proteomics-based strategy.
Kabbage M; Trimeche M; Ben Nasr H; Hammann P; Kuhn L; Hamrita B; Chaieb A; Chouchane L; Chahed K
Tumour Biol; 2012 Dec; 33(6):2279-88. PubMed ID: 22972503
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1).
Zhou J; Xu T; Yan Y; Qin R; Wang H; Zhang X; Huang Y; Wang Y; Lu Y; Fu D; Chen J
PLoS One; 2013; 8(7):e68469. PubMed ID: 23869222
[TBL] [Abstract][Full Text] [Related]
37. [Expression of NOB1 and its significance in colorectal cancer].
Wu DP; He XW
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):420-2. PubMed ID: 22445998
[TBL] [Abstract][Full Text] [Related]
38. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
[TBL] [Abstract][Full Text] [Related]
39. [Expression and clinical significance of adhesive molecule CD44v6 in breast invasive ductal carcinoma].
Lian ZQ; Yang MT; Hou JH; Luo RZ; Wang X; Tang J
Ai Zheng; 2006 Oct; 25(10):1291-5. PubMed ID: 17059779
[TBL] [Abstract][Full Text] [Related]
40. SMAD4 is a potential prognostic marker in human breast carcinomas.
Liu NN; Xi Y; Callaghan MU; Fribley A; Moore-Smith L; Zimmerman JW; Pasche B; Zeng Q; Li YL
Tumour Biol; 2014 Jan; 35(1):641-50. PubMed ID: 23975369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]